Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.

Andrea Hartner; Lisa Jagusch; Nada Cordasic; Kerstin Amann; Roland Veelken; Johannes Jacobi; Karl F Hilgers

doi:10.3389/fphys.2016.00370

Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.

Andrea Hartner, Lisa Jagusch, Nada Cordasic, Kerstin Amann, Roland Veelken, Johannes Jacobi, Karl F Hilgers

Klinik für Innere Medizin 4 - Nephrologie und Hypertensiologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

11 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	370
Fachzeitschrift	FRONTIERS IN PHYSIOLOGY
Jahrgang	7
DOIs	https://doi.org/10.3389/fphys.2016.00370
Publikationsstatus	Veröffentlicht - 2016

Zugriff auf Dokument

10.3389/fphys.2016.00370

Dieses zitieren

@article{2ddd22bcebec4619953dace3f0a7f9a2,

title = "Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.",

keywords = "ENDOTHELIAL GROWTH-FACTOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1, DISK ANGIOGENESIS SYSTEM, END-ORGAN DAMAGE, ANGIOTENSIN-II, BLOOD-PRESSURE, IN-VIVO, ASYMMETRIC DIMETHYLARGININE, PHASE HYPERTENSION, RATS",

author = "Andrea Hartner and Lisa Jagusch and Nada Cordasic and Kerstin Amann and Roland Veelken and Johannes Jacobi and Hilgers, {Karl F}",

year = "2016",

doi = "10.3389/fphys.2016.00370",

language = "English",

volume = "7",

pages = "370",

journal = "FRONTIERS IN PHYSIOLOGY",

issn = "1664-042X",

}

TY - JOUR

T1 - Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension.

AU - Hartner, Andrea

AU - Jagusch, Lisa

AU - Cordasic, Nada

AU - Amann, Kerstin

AU - Veelken, Roland

AU - Jacobi, Johannes

AU - Hilgers, Karl F

PY - 2016

Y1 - 2016

KW - ENDOTHELIAL GROWTH-FACTOR

KW - PLASMINOGEN-ACTIVATOR INHIBITOR-1

KW - DISK ANGIOGENESIS SYSTEM

KW - END-ORGAN DAMAGE

KW - ANGIOTENSIN-II

KW - BLOOD-PRESSURE

KW - IN-VIVO

KW - ASYMMETRIC DIMETHYLARGININE

KW - PHASE HYPERTENSION

KW - RATS

U2 - 10.3389/fphys.2016.00370

DO - 10.3389/fphys.2016.00370

M3 - Original Article

C2 - 27625610

SN - 1664-042X

VL - 7

SP - 370

JO - FRONTIERS IN PHYSIOLOGY

JF - FRONTIERS IN PHYSIOLOGY

ER -